blood sample collection
ProcedureBlood samples from each enrolled participant in CLIN12.1 and/or CLIN12.2 will be collected.
NCT Number: NCT07455136
The study is intended to cover two purposes: first, to develop a blood-based biomarker test for aiding the diagnosis of traumatic brain injury (TBI) in adult participants and for prognosis of outcome of TBI (CLIN12.1); and second, for monitoring the development of secondary events in adult participants diagnosed with TBI (CLIN12.2).
Interested in participating?
Request Info18 year and older
All sexes
Observational
University Of California Davis, Neurological Surgery, Sacramento, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Further Inclusion Criteria (specific for CLIN12.2):
Exclusion criteria
Blood samples from each enrolled participant in CLIN12.1 and/or CLIN12.2 will be collected.
Time frame: Up to 2 weeks post-injury
Time frame: Days 14, 28, and 90
Time frame: Up to 2 weeks post-injury
Time frame: Up to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: Days 14, 28, and 90
Time frame: Days 14, 28, and 90
Time frame: Up to 2 weeks post-injury
Time frame: Up to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: From Day 1 to 2 weeks post-injury
Time frame: Days 14, 28, and 90
Time frame: Days 14, 28, and 90
Time frame: Up to 2 weeks post-injury
Time frame: Up to 2 weeks post-injury
Contact information is provided by the study sponsor or research team.
Hoffmann-La Roche
Industry
A Multicenter Prospective Study to Develop a Blood-based Biomarker Test for Aiding the Diagnosis/Prognosis of Traumatic Brain Injury in Adult Subjects (CLIN12.1) and for Monitoring the Development of Secondary Events in Patients Diagnosed With Traumatic Brain Injury (CLIN12.2)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07732374
Behavior, Brain Concussion
Boise, Idaho, United States
View Trial DetailsNCT05236010
Brain Diseases, Brain Injuries
Minneapolis, Minnesota, United States
View Trial DetailsNCT07719595
Brain Diseases, Brain Injuries
Stony Brook, New York, United States
View Trial DetailsNCT06465290
Brain Diseases, Brain Injuries
Baltimore, Maryland, United States
View Trial Details